Search research articles
Contact Us
Filters
Showing results (261-270 of 320) with videos related to
Page
of 32
Sort By:
Science (New York, N.Y.)
|
February 10, 2007
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak
Simon N Willis, Jamie I Fletcher, Thomas Kaufmann, et al.
Genes & Development
|
October 28, 2018
Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor development
Brandon J Aubrey, Ana Janic, Yunshun Chen, et al.
Cell Death & Disease
|
August 26, 2016
MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL
Ingela B Vikström, Anne Slomp, Emma M Carrington, et al.
Nature
|
October 11, 2002
Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome
Vanessa S Marsden, Liam O'Connor, Lorraine A O'Reilly, et al.
Immunity
|
May 17, 2015
FAS Inactivation Releases Unconventional Germinal Center B Cells that Escape Antigen Control and Drive IgE and Autoantibody Production
Danyal Butt, Tyani D Chan, Katherine Bourne, et al.
Nature Immunology
|
July 10, 2007
Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1
Nicholas D Huntington, Hamsa Puthalakath, Priscilla Gunn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 25, 2014
Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production
Yifan Zhan, Emma M Carrington, Hyun-Ja Ko, et al.
Nature Microbiology
|
August 31, 2016
Eliminating Legionella by inhibiting BCL-XL to induce macrophage apoptosis
Mary Speir, Kate E Lawlor, Stefan P Glaser, et al.
Nature Communications
|
September 27, 2018
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L
Lucia Taraborrelli, Nieves Peltzer, Antonella Montinaro, et al.
Cancer Cell
|
April 26, 2024
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
Sarah T Diepstraten, Yin Yuan, John E La Marca, et al.
Page
of 32
Search research articles
Search
Showing results (261-270 of 320) with videos related to
Sort By:
Page
of 32
Science (New York, N.Y.)
|
February 10, 2007
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak
Simon N Willis, Jamie I Fletcher, Thomas Kaufmann, et al.
Genes & Development
|
October 28, 2018
Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor development
Brandon J Aubrey, Ana Janic, Yunshun Chen, et al.
Cell Death & Disease
|
August 26, 2016
MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL
Ingela B Vikström, Anne Slomp, Emma M Carrington, et al.
Nature
|
October 11, 2002
Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome
Vanessa S Marsden, Liam O'Connor, Lorraine A O'Reilly, et al.
Immunity
|
May 17, 2015
FAS Inactivation Releases Unconventional Germinal Center B Cells that Escape Antigen Control and Drive IgE and Autoantibody Production
Danyal Butt, Tyani D Chan, Katherine Bourne, et al.
Nature Immunology
|
July 10, 2007
Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1
Nicholas D Huntington, Hamsa Puthalakath, Priscilla Gunn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 25, 2014
Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production
Yifan Zhan, Emma M Carrington, Hyun-Ja Ko, et al.
Nature Microbiology
|
August 31, 2016
Eliminating Legionella by inhibiting BCL-XL to induce macrophage apoptosis
Mary Speir, Kate E Lawlor, Stefan P Glaser, et al.
Nature Communications
|
September 27, 2018
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L
Lucia Taraborrelli, Nieves Peltzer, Antonella Montinaro, et al.
Cancer Cell
|
April 26, 2024
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
Sarah T Diepstraten, Yin Yuan, John E La Marca, et al.
Page
of 32